Global Hyaluronic Acid Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Application (Tissue Engineering, Osteoarthritis Treatment, Dermal Filler, Others) And By Geography - Forecasts From 2021 To 2026

  • Published : May 2021
  • Report Code : KSI061613831
  • Pages : 121

The global hyaluronic acid market is projected to augment at a significant CAGR over the forecast period, with an estimated value of USD8.280 billion in 2019. Hyaluronic acid (HA) is naturally available in the human body. In eyes and joints, HA is found in the highest concentrations. The substance has the ability to keep skin plump and moist. Hence, it is utilized by many cosmetic surgeons in the form of injectables to reduce aging on the skin.

The growing global geriatric population is projected to surge the market growth during the forecast period. The presence of companies offering advanced hyaluronic acid solutions for the customers worldwide is further augmenting the market growth during the forecast period. Hyaluronic acid can be found in the form of serums, sheet masks, and dermal fillers. Popular brand names for hyaluronic acid fillers include Juvederm, Elevess, Puragen, and Captique among others. The growing adoption of minimally-invasive procedures for cosmetic procedures is further propelling the market growth during the forecast period.

On the basis of geography, the market is segmented into North America, South America, Europe, Middle East and Africa, and the Asia Pacific region. North America is projected to hold a significant market share owing to the early adoption of technologies and innovation. Additionally, the substantial aging population along with increasing susceptibility to age-associated diseases like osteoarthritis is further contributing to fueling the market demand during the forecast period. The Asia Pacific region is estimated to account for holding a substantial market share owing to the increasing interests towards the adoption of anti-aging products.

The novel coronavirus infection scenario is predicted to impede the market growth in 2020 owing to the lockdown measures. The closure of aesthetic and cosmetic clinics has further put an impact on affecting the market growth amid the COVID-19 pandemic situation compared to the pre COVID-19 situation.

global hyaluronic acid market

The soaring dermal filler procedures worldwide is augmenting the growth of the global hyaluronic acid market during the forecast period.

The market is projected to soar with the growing dermal filler procedures in the world. There is an increasing interest among consumers to look young and thus this has surged the demand for cosmetic procedures that include the hyaluronic acid dermal filler consumption, further propelling the market demand during the forecast period. The dermal fillers help in filling wrinkles and are utilized to add volume to the soft tissues, thus giving them a full and voluptuous look. These gel injections are inserted in different areas of the body that include lips, cheeks, jawline, and lips. Other factors fueling the demand for dermal filler procedures include the immediate effects observed after application. This reduces the signs of aging and provides consumers the near-instant satisfaction. The currently growing selfie trend and uploading it on the social media platform had raised the growth prospects of these procedures. Consumers seek for measures that make them look beautiful while posting pictures on the social media platforms. The increasing aging worldwide is further augmenting the market growth demanding dermal filler procedures during the forecast period. The total population 65 years of age and above is predicted to surge from 55,11,19,375 in 2012 to 69,79,67,728 in 2019 (source: The World Bank).

global hyaluronic acid market by age

The increasing interest of men to look their best, apart from women is further adding to surging the demand for dermal fillers, propagating the market growth during the forecast period. These group of people are quite comfortable with the available aesthetic procedures offering innovative options to enhance their looks. Additionally, the convenient methods to administer hyaluronic acid into the human skin are further propelling the market demand owing to the consumer friendliness of the cosmetic procedures that are minimally invasive and are least painful offering huge gain.

With the increasing disposable income worldwide, especially, in the developing regions of the world, the demand for dermal fillers are continuing to grow. This is mainly attributed to increasing consumer spending ability, further offering them options to look above their basic expenditures and hence, are willing to spend on sophisticated cosmetic procedures. According to the National Bureau of Statistics Data, the per capita consumer spending in China rose to achieve 21,559 yuan in 2019, an increase by 5.5% y-o-y.

There is a wide availability of dermal fillers in the market, these include temporary, permanent, and semi-permanent fillers. Most of the non-permanent fillers are safer to use and are FDA approved, these include hyaluronic-based fillers as well. 

The presence of companies offering innovative hyaluronic acid-based products are fueling the market growth during the forecast period.

Galderma, focused on the offering science-based solutions for skin health through its Restylane® brand offers a diverse range of hyaluronic-acid based commodities segregated into two product groups namely, Restylane fillers and Restylane Skinboosters.

The fillers category is a combination of two unique technologies involving OBT and NASHTA™. These have further established safety profile for more than two decades of experience, Offers high patient satisfaction with around 40 million treatments in the world. The product portfolio includes Restylane Fynesse™, Restylane Refyne™, Restylane, and Restylane Volyme™ for restoration of youthful appearance that include filling fine lines and wrinkles, and replacing the lost fullness and volume due to aging. Restylane Defyne™, Restylane Lyft™, and Restylane Kysse™ are used for enhancing the appearance for the creation of harmony and balance and for the enhancement of the shape, contour, and definition.

The Skinboosters category offers solutions for skin rejuvenation for delivering hydration and skin imperfection improvement, thus leading to a radiant and healthy skin.

Humedix Co., Ltd. offers hyaluronic acid as the active pharmaceutical ingredient for applications in eye drops, ophthalmology injection, beauty filler, and osteoarthritis drug.

Kewpie Corporation offers hyaluronic acid for cosmetic applications. Products include HAbooster™, Hyalo-Oligo®, Hyaloveil®-P, and Hyalorepair®. The HAbooster is a collagen cycle accelerator hyaluronic acid, a novel product having super low molecular weight of around 2000. Further promoting collagen cycle and increasing skin moisture. The low molecular hyaluronic acid, Hyalo-oligo have an average molecular weight lesser than 10,000. It soaks into the skin hard layer and imparts moisture from inside the skin. Hyaloveli-P is a hyaluronic acid containing adsorptive property that stays in hair and on the skin even when rinsed with water. Hence this contributes to sustained moisture even after the washing-off of the hyaluronic acid. Hyalorepair is a lamellar structure reviving hyaluronic acid that contains the properties of hydrophilic and hydrophobic groups. This further contributed to enhancing and reviving of the skin’s barrier functionality, further resulting in a smoother skin.

Significant product launches indicating continuous innovation in the field of hyaluronic acid is further augmenting the market growth during the forecast period in addition to offering the strong prospects for generating high revenues.

The launching of a skincare capsule by Taut USA in 2019 was announced. The capsule, TautHydrate is a one hundred percent vegan hyaluronic acid and grape seed extract supplement. The product is designed for skin hydration and plump from within. The capsule is based on the plant-derived and proprietary fermentation procedure of non-animal origin. This is further highly pure and of low molecular weight, hence is capable of penetrating in skin cells. The product is focused on vegan customers demanding natural and clean product. Additionally, the product is an excellent alternative for hyaluronic acid-based injections as everyone is not capable of affording highly-priced fillers.

In 2019, Alma declared the launch of Profhilo®. This is an advanced hyaluronic acid-based product for aesthetic procedures in Hong Kong. The product is an entirely novel injectable category known as bioremodeling, it works through the engaging with body’s receptors and helps in the stimulation of collagen growth. In comparison to the standard dermal fillers, the product is capable of distributing itself conveniently withing the tissues of the skin. Thus, resulting in a healthier and more elastic skin for the patients. The overall product contains benefits derived from both the dermal filler world and skin rejuvenation treatment procedures.

In 2019, Protocol, the collagen brand announced the launch of innovative collagen products. This was declared with the launch of collagen and hyaluronic acid capsules. The product utilizes the advanced technology of verisol with bioactive collagen peptides in addition to the moisture binding ingredient, hyaluronic acid. The formula is scientifically proven for reduction of wrinkles and reduction in the appearance of fine lines, thus contributing to increasing the skin elasticity and encouraging cell proliferation. Further resulting in healthy cells in less than four weeks. The product benefits include increasing pro-collagen production by more than 60%, enhancing skin elasticity by 15%, wrinkle reduction by 20%, and improvement in wound healing after surgical intervention, reduction in the appearance of cellulite, and improvement of brittle nails.

In 2020, JW Pharmaceutical declared the launch of a hyaluronic acid filler, initium in South Korea. The product consists of 3 state product line that include 2 bi-phasic products, and 1 mono-phasic product.

Global Hyaluronic Acid Market Scope:

Report Metric Details
 Market size value in 2019  US$8.280 billion
 Growth Rate  CAGR over the forecast period
 Base year  2019
 Forecast period  2021–2026
 Forecast Unit (Value)  USD Billion
 Segments covered  Application, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Allergan (AbbVie Inc.), Sanofi, Seikagaku Corporation, Contipro a.s., BioScience GmbH, Kewpie Corporation, Bohus BioTech AB, Humedix.Co.Ltd, Anika Therapeutics, Inc., Laboratoires Vivacy, S.A.S., Cosmedica Skincare, Wellona Pharma, Plamed   Green Science Group, Revitajal (Beauty Aesthetic Finland Oy), Altergon Italy Srl
 Customization scope  Free report customization with purchase



  • By Application
    • Tissue Engineering
    • Osteoarthritis Treatment
    • Dermal Filler
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Others
    • Middle East and Africa
      • UAE
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Others

Frequently Asked Questions (FAQs)

Q1. What is the size of global hyaluronic acid market?
A1. The global hyaluronic acid market was valued at USD8.280 billion in 2019. 

Q2. What is the base year considered in the hyaluronic acid market report?
A2. 2019 has been taken as the base year in the hyaluronic acid market.

Q3. How is the global hyaluronic acid market segmented?
A3. The hyaluronic acid market has been segmented by application and geography.

Q4. What factors are anticipated to drive the hyaluronic acid market growth?
A4. The growing global geriatric population is projected to surge the market growth during the forecast period.

Q5. Which region holds the largest market share in the hyaluronic acid market?
A5. North America is projected to hold a significant market share owing to the early adoption of technologies and innovation.

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. Global Hyaluronic Acid Market Analysis, by Application
5.1. Introduction
5.2. Tissue Engineering
5.3. Osteoarthritis Treatment 
5.4. Dermal Filler
5.5. Others
6. Global Hyaluronic Acid Market Analysis, by Geography
6.1. Introduction
6.2. North America
6.2.1. North America Hyaluronic Acid Market, By Application, 2019 to 2025
6.2.2. By Country United States Canada Mexico
6.3. South America
6.3.1. South America Hyaluronic Acid Market, By Application, 2019 to 2025
6.3.2. By Country Brazil Argentina Others
6.4. Europe
6.4.1. Europe Hyaluronic Acid Market, By Application, 2019 to 2025
6.4.2. By Country UK Germany France Others
6.5. Middle East and Africa
6.5.1. Middle East and Africa Hyaluronic Acid Market, By Application, 2019 to 2025
6.5.2. By Country United Arab Emirates Israel Saudi Arabia Others
6.6. Asia Pacific
6.6.1. Asia Pacific Hyaluronic Acid Market, By Application, 2019 to 2025
6.6.2. By Country Japan China India Australia Others
7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. Company Profiles 
8.1. Allergan (AbbVie Inc.)
8.2. Sanofi
8.3. Seikagaku Corporation 
8.4. Contipro a.s.
8.5. BioScience GmbH 
8.6. Kewpie Corporation 
8.7. Bohus BioTech AB
8.8. Humedix.Co.Ltd
8.9. Anika Therapeutics, Inc.  
8.10. Laboratoires Vivacy, S.A.S.
8.11. Cosmedica Skincare
8.12. Wellona Pharma
8.13. Plamed Green Science Group
8.14. Revitajal (Beauty Aesthetic Finland Oy)
8.15. Altergon Italy Srl

Allergan (AbbVie Inc.)


Seikagaku Corporation

Contipro a.s.

BioScience GmbH

Kewpie Corporation

Bohus BioTech AB


Anika Therapeutics, Inc. 

Laboratoires Vivacy, S.A.S.

Cosmedica Skincare

Wellona Pharma

Plamed Green Science Group

Revitajal (Beauty Aesthetic Finland Oy)

Altergon Italy Srl